Sectors
BDTX
Black Diamond Therapeutics, Inc.
2.10
2 x 1.58
2 x 2.72
bid
ask
-
0.13
5.83%
2 @ 07:57 PM
2.15 +0.05 (2.33%)
| Ytd | -13.58% | |
| 1y | -23.64% |
2.10
day range
2.23
1.60
52 week range
4.94
| Open | 2.22 | Prev Close | 2.23 | Low | 2.10 | High | 2.23 | Mkt Cap | 120.33M |
| Vol | 509.28K | Avg Vol | 1.22M | EPS | -0.75 | P/E | N/A | Forward P/E | -1.80 |
| Beta | 2.52 | Short Ratio | 11.67 | Inst. Own | 98.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 1.91 | 200-d Avg | 2.45 | 1yr Est | 14.50 |
| Income Statement | |||
| Operating Expenses | 12.06M | ||
| Research and Development Expense | 7.39M | ||
| Selling, General and Administrative Expense | 4.66M | ||
| Operating Income | -12.06M | ||
| Net Income | -9.90M | ||
| Net Income Common Stock | -9.90M | ||
| Net Income Common Stock (USD) | -9.90M | ||
| Consolidated Income | -9.90M | ||
| Earnings per Basic Share | -0.17 | ||
| Earnings per Basic Share (USD) | -0.17 | ||
| Earnings per Diluted Share | -0.17 | ||
| Earning Before Interest & Taxes (EBIT) | -9.90M | ||
| Earning Before Interest & Taxes (USD) | -9.90M | ||
| Weighted Average Shares | 57.37M | ||
| Weighted Average Shares Diluted | 57.37M | ||
| Balance Sheet | |||
| Cash and Equivalents | 20.03M | ||
| Cash and Equivalents (USD) | 20.03M | ||
| Investments | 91.31M | ||
| Investments Current | 91.31M | ||
| Current Assets | 115.39M | ||
| Property, Plant & Equipment Net | 8.52M | ||
| Total Assets | 125.03M | ||
| Total Debt | 13.10M | ||
| Current Liabilities | 15.84M | ||
| Debt Non-Current | 13.10M | ||
| Total Liabilities | 28.94M | ||
| Accumulated Retained Earnings (Deficit) | -483.68M | ||
| Accumulated Other Comprehensive Income | -68.00K | ||
| Shareholders Equity | 96.09M | ||
| Shareholders Equity (USD) | 96.09M | ||
| Assets Non-Current | 9.64M | ||
| Total Debt (USD) | 13.10M | ||
| Liabilities Non-Current | 13.10M | ||
| Trade and Non-Trade Payables | 1.40M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 28.00K | ||
| Net Cash Flow from Financing | 217.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.87M | ||
| Issuance (Purchase) of Equity Shares | 217.00K | ||
| Net Cash Flow from Investing | -3.12M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.12M | ||
| Net Cash Flow from Operations | -7.97M | ||
| Share Based Compensation | 1.51M | ||